Tags |
|
|
E-Folder - 'Forming' A Team: What Does It Mean And How Do I Do It?
Most people have come across Bruce Tuckman’s model of team development and its four stages: forming, norming, storming and performing. You may know it as a five-stage model, as Tuckman added a fifth phase in the 1970s: adjourning.
Whilst most of us are familiar with the model and probably broadly aware of the chara
Whilst most of us are familiar with the model and probably broadly aware of the chara
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
cteristics of each of the stages, managers and leaders are often unsure just how those characteristics manifest themselves in real life and, more to the point, what they should do to help their teams progress to the next stage.
In the original article in which he first put forward his model, Tuckman described this
In the original article in which he first put forward his model, Tuckman described this
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
tage as follows:
“Groups initially concern themselves with orientation accomplished primarily through testing. Such testing serves to identify the boundaries of both interpersonal and task behaviors. Coincident with testing in the interpersonal realm is the establishment of dependency relationships w
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ith leaders, other group members, or pre-existing standards. It may be said that orientation, testing and dependence constitute the group process of forming.”
The key words here are orientation, testing and dependence. In this phase of development, members are trying to find th
The key words here are orientation, testing and dependence. In this phase of development, members are trying to find th
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ir place, or role, in the team. Their focus is on their individual needs and on developing a relationship with the leader and members rely heavily on the team leader for direction.
It is usually easy to understand the concept of the forming stage of a team’s development when the team is entirely new, and there is l
It is usually easy to understand the concept of the forming stage of a team’s development when the team is entirely new, and there is l
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
iterature galore to be found on the subject. It is much more difficult to find any specific information about what it means when the team is pre-existing but the leader is new.
New leaders often join an existing team with the view that it is already formed and that are simply joining it in an already mature state.
New leaders often join an existing team with the view that it is already formed and that are simply joining it in an already mature state.
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
t is, however, widely accepted that when a new leader joins a team the team’s development reverts to the forming stage regardless of where it was previously at. The length of time it stays in this phase depends on a combination of the maturity of the team and on the skill of the leader.
So as a new leader, how do y
So as a new leader, how do y
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ou recognise the signs that your team has reverted to the forming stage and what can you do to help the team through it?
- Each individual is focused on his/her own objectives. They are not sure whether the overall team objectives are still the same or whether you will change everything. Some members may be
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
experiencing some anxiety in terms of their desire to impress the new boss.
Whilst positive relationships may exist between members of the team, there are no relationships with you. There is no trust yet established between you. Team members will be watching and assessing you to see how you respond to diff
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
erent situations. Your behaviour and reactions will potentially have huge impact in terms of how quickly your team members will decide whether you are competent and start to trust you.
There may be some politicking going on within the group. It may be that the team has been leaderless for some time prior t
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
your joining, in which case maybe a team member was taking the role of leader for an interim period. That person may be disappointed, or even resentful, of your arrival to lead the team. There may be allegiances that you are unaware of. Watch for unexplained failure to cooperate or support your integration to the t
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
am.
Team members may be questioning their roles in the team. In the time they have been together they will have settled into roles that play to their individual strengths. Some may wonder whether you will change that. They may fear that weaknesses will be exposed. Be conscious of this when you allocate res
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ponsibilities and tasks to team members.
You may notice some power games being played. It is likely that your team members know more about the function, processes and tasks for which they are responsible. It is within their power to help you to learn them or to keep it to themselves. You may notice some un
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
illingness to let you in on the team ‘secrets’.
This may all seem very negative, and it is unlikely that you will find all of these things going on at once. If you do, however, remember that these behaviours are symptomatic of concern about change, and where you can alleviate your team members’ concerns
This may all seem very negative, and it is unlikely that you will find all of these things going on at once. If you do, however, remember that these behaviours are symptomatic of concern about change, and where you can alleviate your team members’ concerns
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
you can progress to the next stage of developing your team.
Some suggested leadership interventions you might make to achieve this:
Some suggested leadership interventions you might make to achieve this:
- Ensure that you have the same understanding as your existing team members of what the team is required to deliver. Get everyone together and discuss it. Clarify the key del
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
verables and timescales. Identify where the team is up to in terms of delivery, and where there are issues.
Take the time early on to set objectives with each individual team member. Be clear about what you expect. Talking this through with them and agreeing the way forward will serve to establish some gro
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
und rules, and will alleviate much of any concern they may have about how you perceive them or their work.
Help the team to get to know you. Left to its own devices, this can be a long and tedious process. Team members will form their own perceptions of you, and you of them. Consider undertaking a facilita
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ed exercise where you help the team to know more about you as a person as well as a leader, and vice-versa.
Provide a lot of direction. Many new leaders join teams and try to leave the team to its own devices, almost taking a subordinate role in the early days. This doesn’t tend to work. In this phase, tea
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
m members do not yet know your style or your standards. They don’t want to get it wrong, so they will look to you to tell them what they should be doing until they become more comfortable with you.
Meet regularly with the individual members of your team, and communicate, communicate, communicate.
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
>
These five simple steps are just some of the things you can start to do right now to form the team you want from the team you have. Start implementing these and you’ll be well on your way to the next stage of the team’s development and ultimately to high performance.
© Allagi Consulting 2007. All Rights Reserve
These five simple steps are just some of the things you can start to do right now to form the team you want from the team you have. Start implementing these and you’ll be well on your way to the next stage of the team’s development and ultimately to high performance.
© Allagi Consulting 2007. All Rights Reserve
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-folder.org.ua/article/45449/e-folder-Forming-A-Team-What-Does-It-Mean-And-How-Do-I-Do-It.html">'Forming' A Team: What Does It Mean And How Do I Do It?</a>
BB link (for phorums):
[url=http://www.e-folder.org.ua/article/45449/e-folder-Forming-A-Team-What-Does-It-Mean-And-How-Do-I-Do-It.html]'Forming' A Team: What Does It Mean And How Do I Do It?[/url]
Related Articles:
Should you Measure Individual People's Performance?
Why Have Personal Business Cards?
More Information on the Move with Sage SalesLogix Mobile v4
Bookmark it:
|